Breathing training from home shows promise for DMD children
NCT ID NCT07172737
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested whether breathing muscle exercises done at home via video calls could improve lung function and quality of life in 40 children with Duchenne muscular dystrophy. The children, aged 5-17, used a device to strengthen their breathing muscles. Researchers measured changes in breathing strength and daily breathlessness. The goal is to find a simple, accessible way to help manage respiratory problems in DMD.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Functional inspiratory muscle training via tele-rehabilitation
- What this could lead to
- If it works, this could offer a convenient home-based way to help children with Duchenne muscular dystrophy breathe easier and improve daily life.
- What could go wrong
- This is a small, completed study with only 40 participants. Results may not apply to all children with DMD, and the benefits might be modest.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
40 people
The number who actually took part.
- Started
-
May 2024
- Finished
-
May 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
5 to 17 years
- Sex
-
Male participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Being between the ages of 5-17 2. Ambulate 3. Having a diagnosis of DMD based on the presence of clinical symptoms, genetic testing or muscle biopsy results 4. Having the ability to perform respiratory function tests 5. Being able to cooperate with the physiotherapist Exclusion Criteria: 1. Having severe upper extremity contracture or serious systemic disease that would prevent our evaluation 2. Having a respiratory tract infection in the last 3 months 3. Having had an injury or surgery on both upper extremities in the last 6 months
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Duchenne muscular dystrophy are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Tepecik training and research hospital
Izmir, Konak, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new dosing schedule tame steroid side effects in duchenne?
- Can a daily supplement ease the toll of duchenne muscular dystrophy?
- Can a lower steroid dose preserve strength in young boys with DMD?
- Can a targeted infusion slow muscle decline in duchenne? a new trial aims to find out.
- Can a massive patient database unlock new treatments for muscular dystrophy?
- Umbilical cord stem cells aim to slow muscle loss in duchenne boys